Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 1,417 | 1,690 | 1,415 | 1,435 | 1,456 |
| Operating Income | -1,417 | -1,690 | -1,415 | -1,435 | -1,456 |
| Other Income | 29 | 36 | 50 | 37 | 34 |
| Pre-tax Income | -1,388 | -1,654 | -1,365 | -1,398 | -1,422 |
| Net Income Continuous | -1,388 | -1,654 | -1,365 | -1,398 | -1,422 |
| Net Income | $-1,388 | $-1,654 | $-1,365 | $-1,398 | $-1,422 |
| EPS Basic Total Ops | -0.06 | -0.08 | -0.07 | -0.07 | -0.08 |
| EPS Basic Continuous Ops | -0.06 | -0.08 | -0.06 | -0.07 | -0.08 |
| EPS Diluted Total Ops | -0.06 | -0.08 | -0.07 | -0.07 | -0.08 |
| EPS Diluted Continuous Ops | -0.06 | -0.08 | -0.06 | -0.07 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.08 | -0.07 | -0.07 | -0.08 |
| EBITDA(a) | $-1,182 | $-1,430 | $-1,163 | $-735 | $-118 |